These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34813872)

  • 41. [Interpretation of group standard for
    Wu Y; Lu JX; Yan ZZ; Liu YX; Gu WP; Fu XQ; Xu YC; Wu AH; Huang HH; Zong ZY; Jin DZ; Zhao JH; Chen Y; Liu WP; Li WG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jan; 42(1):64-67. PubMed ID: 33503698
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Holding firm: Use of clinical correlation to improve Clostridioides difficile testing.
    Baghdadi J; Ganz DA; Chumpia M; Chang ET; de Peralta SS
    Am J Infect Control; 2020 Sep; 48(9):1104-1107. PubMed ID: 31862165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.
    McGovern BH; Ford CB; Henn MR; Pardi DS; Khanna S; Hohmann EL; O'Brien EJ; Desjardins CA; Bernardo P; Wortman JR; Lombardo MJ; Litcofsky KD; Winkler JA; McChalicher CWJ; Li SS; Tomlinson AD; Nandakumar M; Cook DN; Pomerantz RJ; Auninš JG; Trucksis M
    Clin Infect Dis; 2021 Jun; 72(12):2132-2140. PubMed ID: 32255488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of a stewardship intervention focused on reducing unnecessary use of non-
    Hecker MT; Son AH; Alhmidi H; Wilson BM; Wiest PM; Donskey CJ
    Infect Control Hosp Epidemiol; 2020 Feb; 41(2):216-218. PubMed ID: 31843033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic stewardship and the 2017 update of the IDSA-SHEA Clinical Practice Guidelines for Clostridium difficile Infection.
    Madden GR; Poulter MD; Sifri CD
    Diagnosis (Berl); 2018 Sep; 5(3):119-125. PubMed ID: 29990306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
    [No Abstract]   [Full Text] [Related]  

  • 47. Diagnosing Clostridioides difficile infections with molecular diagnostics: multicenter evaluation of revogene C. difficile assay.
    Sambri V; Gateau C; Zannoli S; Dirani G; Couturier J; Op den Buijs I; Roymans R; Hallet E; Arnold M; Zumoberhaus A; Steiner S; van de Bovenkamp J; Altwegg M; Berlinger L; Barbut F;
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1169-1175. PubMed ID: 32062723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Economic evaluation of interventions designed to reduce Clostridium difficile infection.
    Brain D; Yakob L; Barnett A; Riley T; Clements A; Halton K; Graves N
    PLoS One; 2018; 13(1):e0190093. PubMed ID: 29298322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
    Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
    Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using Clinical Scenarios to Understand Preventability of Clostridium difficile Infections by Inpatient Antibiotic Stewardship Programs.
    Seidelman J; Dicks KV; Durkin MJ; Baker AW; Moehring RW; Anderson DJ; Sexton DJ; Chen LF; Lewis SS
    Infect Control Hosp Epidemiol; 2017 Jun; 38(6):747-749. PubMed ID: 28285605
    [No Abstract]   [Full Text] [Related]  

  • 51. Clostridioides difficile Infection: Update on Management.
    Mounsey A; Lacy Smith K; Reddy VC; Nickolich S
    Am Fam Physician; 2020 Feb; 101(3):168-175. PubMed ID: 32003951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utilizing a real-time discussion approach to improve the appropriateness of
    Dbeibo L; Brinkman A; Beeler C; Fadel W; Snyderman W; Hatfield N; Sadowski J; Wang Y; Kelley K; Webb D; Azar J; Kara A
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1215-1218. PubMed ID: 32594961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent developments in the management of recurrent Clostridioides difficile infection.
    Mendo-Lopez R; Villafuerte-Gálvez J; White N; Mahoney MV; Kelly CP; Alonso CD
    Anaerobe; 2020 Apr; 62():102108. PubMed ID: 31606481
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnosis and management of paediatric Clostridioides difficile infection in a tertiary centre: A prospective audit.
    Gates V; Best E; Roberts S; Swager T; Voss L
    J Paediatr Child Health; 2021 Apr; 57(4):500-506. PubMed ID: 33145899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Costs Associated with the Treatment of Clostridioides Difficile Infections.
    Sierocka A; Kiersnowska Z; Lemiech-Mirowska E; Marczak M
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost and length of hospital stay for healthcare facilityonset Clostridioides Difficile infection in pediatric wards: a prospective cohort analysis.
    Demir SÖ; Kepenekli E; Akkoç G; Yakut N; Soysal A
    Turk J Pediatr; 2021; 63(6):1004-1011. PubMed ID: 35023650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modeling inpatient and outpatient antibiotic stewardship interventions to reduce the burden of Clostridioides difficile infection in a regional healthcare network.
    Rhea S; Jones K; Endres-Dighe S; Munoz B; Weber DJ; Hilscher R; MacFarquhar J; Sickbert-Bennett E; DiBiase L; Marx A; Rineer J; Lewis J; Bobashev G;
    PLoS One; 2020; 15(6):e0234031. PubMed ID: 32525887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of a Safety Program for Improving Antibiotic Use With Antibiotic Use and Hospital-Onset Clostridioides difficile Infection Rates Among US Hospitals.
    Tamma PD; Miller MA; Dullabh P; Ahn R; Speck K; Gao Y; Scherpf E; Cosgrove SE
    JAMA Netw Open; 2021 Feb; 4(2):e210235. PubMed ID: 33635327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An emergent infectious disease: Clostridioides difficile infection hospitalizations, 10-year trend in Sicily.
    Medaglia AA; Buffa S; Gioè C; Bonura S; Rubino R; Iaria C; Colomba C; Cascio A
    Infection; 2021 Dec; 49(6):1221-1229. PubMed ID: 34495497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current management of Clostridioides (Clostridium) difficile infection in adults: a summary of recommendations from the 2017 IDSA/SHEA clinical practice guideline.
    Ma J; Dubberke E
    Pol Arch Intern Med; 2019 Mar; 129(3):189-198. PubMed ID: 30457126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.